Get 30% Off Your First Skin Rejuvenation Service As A New Client

Wegovy - Medical Weight Injections

Wegovy is an FDA-approved self-injectable medication designed to support long-term weight loss and weight management.

FDA Approved

Reduced Cravings

Improved Metabolic Health

Long-Term Weight Management

What Is Wegovy™ (semaglutide)?

Wegovy® (semaglutide) is an FDA-approved medication for weight loss and long-term weight management. As a GLP-1 receptor agonist, it helps regulate blood sugar, reduce appetite, and improve metabolic function—making it an effective solution for weight reduction.

Why Choose Wegovy?

  • Clinically proven to help patients lose an average of 17% of their body weight within one year
  • Recently FDA-approved for weight loss (same active ingredient as Ozempic)
  • Promotes faster satiety and longer-lasting satisfaction
  • Enhances your body’s ability to process sugars for improved metabolic health

 

To learn more about real patient experiences at Coastal Wellness MD, explore Wegovy’s FDA approval, and review clinical insights from the Novomedlink case study.

Most patients see an average weight loss of around 35 pounds

Quick & Hassle-Free Reservations

 Choose your preferred date and time in just a few clicks. Our user-friendly system makes it easy to reserve your spot—no phone calls, no waiting.

 Once you book, you’ll receive immediate confirmation and reminders, so you’re always in the loop about your upcoming appointment.

Whether it’s an urgent concern or a general wellness check, our experienced team is here to diagnose and treat you with compassion, efficiency, and comfort—right when you need it most.

FAQ's

Yes. Wegovy is FDA-approved for weight loss. Wegovy uses semaglutide, a GLP-1 agonist with strong clinical results.

They mimic the body’s natural GLP-1 hormone to reduce hunger, delay gastric emptying, and help regulate blood sugar.

On average, patients lose 15–20% of their body weight with consistent use and lifestyle support.

Yes, when prescribed and monitored appropriately. Common side effects include nausea, constipation, or bloating—usually temporary.

Patients with personal or family history of medullary thyroid cancer, MEN2 syndrome, or pancreatitis are not candidates.

Yes, we run a comprehensive blood panel to check kidney, liver, thyroid function, and blood sugar before starting.

All are weekly subcutaneous injections. We train you virtually or in-person.

Nausea, constipation, fatigue, and bloating are common. Rarely, patients may experience gallbladder issues or pancreatitis.

Connect With Our Team

Your wellness experience starts here. Submit your inquiry and we’ll take care of the rest.